Skip to main content

Table 1 Characteristics of HIV-infected adults at admission, by outcome at discharge, in three nutritional therapy programmes in Kenya and Uganda, 2006-2008

From: Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study

Characteristics

Cured n = 524 (47.4%)

Not cured n = 149 (13.5%)

Defaulted n = 250 (22.6%)

Died n = 132 (11.9%)

Otheran = 51 (4.6%)

Total N = 1106

Demographic factors

      

Women (%)

323 (61.6)

79 (53.0)

128 (51.2)

64 (48.5)

33 (64.7)

627 (56.7)c

Median age, years [IQR]

32 [27-40]

35 [29-40]

33 [27-40]

34 [30-42]

35 [27-44]

33 [28-40]f

Follow up in HIV care

      

New patients (%)

398 (76.0)

116 (77.9)

208 (83.2)

102 (77.3)

32 (62.8)

856 (77.4)d

In HIV care (%)

126 (24.0)

33 (22.1)

42 (16.8)

30 (22.7)

19 (37.2)

250 (22.6)

Nutritional status a

      

BMI, kg/m2, median [IQR]

16.0 [15.4-16.5]

15.5 [14.6-16.3]

15.6 [14.3-16.3]

15.2 [14.0-16.2]

15.5 [14.3-16.4]

15.8 [14.9-16.4]e

Severe malnutrition, BMI <16 kg/m2 (%)

245 (46.8)

96 (64.4)

157 (62.8)

91 (68.9)

28 (54.9)

617 (55.8)e

Moderate malnutrition, BMI 16-17 kg/m2 (%)

279 (53.2)

53 (35.6)

93 (37.2)

41 (31.1)

23 (45.1)

489 (44.2)

Clinical & immunological factors

      

Non-cumulative HIV clinical stage (%)

n = 508

n = 143

n = 242

n = 128

n = 49

n = 1070 c

Asymptomatic

40 (7.9)

10 (7.0)

20 (8.3)

12 (9.4)

5 (10.2)

87 (8.1)

1 or 2

149 (29.3)

48 (33.5)

50 (20.7)

21 (16.4)

10 (20.4)

278 (26.0)

3

248 (48.8)

65 (45.5)

119 (49.2)

65 (50.8)

23 (46.9)

520 (48.6)

4

71 (14.0)

20 (14.0)

53 (21.8)

30 (23.4)

11 (22.5)

185 (17.3)

CD4 cell counts, cells/mm 3

n = 411

n = 119

n = 155

n = 83

n = 38

n = 806 e

Median [IQR]

122 [46-272]

188 [86-360]

94 [24-232]

39 [17-126]

74 [42-206]

114 [37-268]

<50 (%)

111 (27.0)

25 (21.0)

61 (39.3)

46 (55.5)

14 (36.8)

257 (31.9)

50-200 (%)

161 (39.2)

36 (30.3)

46 (29.7)

24 (28.9)

14 (36.8)

281 (34.9)

>200 (%)

139 (33.8)

58 (48.7)

48 (31.0)

13 (15.7)

10 (26.4)

268 (33.2)

ART status (%)

      

Not eligible for ART

132 (25.2)

56 (37.6)

89 (35.6)

29 (22.0)

10 (19.6)

316 (28.6)e

On ART

68 (13.0)

17 (11.4)

23 (9.2)

20 (15.2)

5 (9.8)

133 (12.0)

ART started at/after admission

298 (56.8)

70 (47.0)

46 (18.4)

36 (27.3)

20 (39.2)

470 (42.5)

Eligible but no ART

26 (5.0)

6 (4.0)

92 (36.8)

47 (35.5)

16 (31.4)

187 (16.9)

ART regimen (%) b

n = 68

n = 17

N = 23

n = 20

n = 5

n = 133 f

2 NRTI + 1 NNRTI

64 (94.1)

17 (100)

22 (95.7)

20 (100)

5 (100)

128 (96.2)

Second-line therapy

1 (1.5)

0 (0.0)

1 (4.3)

0 (0.0)

0 (0.0)

2 (1.5)

ART interrupted

3 (4.4)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (2.3)

  1. aNo patients had recorded presence of bilateral oedema
  2. bAmong the 133 patients already receiving ART at NP admission
  3. cP < 0.01
  4. dP = 0.02
  5. eP < 0.0001
  6. fP ≥ 0.05
  7. ART - antiretroviral therapy; BMI - body mass index; IQR - interquartile range; NRTI - nucleoside reverse transcriptase inhibitor; NNRTI - non-nucleoside reverse transcriptase inhibitor